Hsieh M C, Lin S F, Shin S J, Liu T C, Chang J G, Lee J P
Department of Internal Medicine, Kaohsiung Medical University Hospital, Taiwan.
Kaohsiung J Med Sci. 2000 Jan;16(1):9-12.
Recently, a putative tumor suppressor gene, PTEN/MMAC1, has been identified at chromosome 10q23.3. This gene encodes a 403 amino acid dual specificity phosphatase containing a region of homology to tensin and auxillin. Somatic mutations of the PTEN/MMAC1 gene have been found in a number of cancer cell lines and primary cancers. Cowden disease, an autosomal dominant harmartoma syndrome associated with thyroid and breast tumors, has been found to be associated with mutations of PTEN/MMAC1 gene. To evaluate the role of the PTEN/MMAC1 gene in sporadic thyroid tumors, we studied 17 sporadic thyroid tumors, of which 12 were papillary thyroid carcinomas, 1 was follicular thyroid carcinoma, 1 was medullary thyroid carcinoma and 3 were thyroid adenomas. Direct sequencing of PCR-amplified products was performed for all nine exons of PTEN/MMAC1. No mutations of PTEN/MMAC1 gene were observed in any of the sporadic thyroid tumors. Our results indicate that the PTEN/MMAC1 gene may not play a major role in sporadic thyroid tumors.
最近,一个假定的肿瘤抑制基因PTEN/MMAC1在染色体10q23.3上被鉴定出来。该基因编码一种含403个氨基酸的双特异性磷酸酶,其含有与张力蛋白和辅助蛋白同源的区域。在许多癌细胞系和原发性癌症中已发现PTEN/MMAC1基因的体细胞突变。考登病是一种与甲状腺和乳腺肿瘤相关的常染色体显性错构瘤综合征,已发现其与PTEN/MMAC1基因突变有关。为了评估PTEN/MMAC1基因在散发性甲状腺肿瘤中的作用,我们研究了17例散发性甲状腺肿瘤,其中12例为甲状腺乳头状癌,1例为甲状腺滤泡癌,1例为甲状腺髓样癌,3例为甲状腺腺瘤。对PTEN/MMAC1的所有9个外显子进行了PCR扩增产物的直接测序。在任何散发性甲状腺肿瘤中均未观察到PTEN/MMAC1基因的突变。我们的结果表明,PTEN/MMAC1基因可能在散发性甲状腺肿瘤中不发挥主要作用。